dsm-firmenich Q1 2024 trading update
KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, May 2, 2024 /PRNewswire/ — Management Report1 Q1 2024 highlights Strong performance in Perfumery & Beauty on good demand developmentGood performance in Taste, Texture & Health underpinned by market recoveryHealth, Nutrition & Ca
CHEVRON APARTMENTS PTY LTD ANNOUNCE THE OFFERING OF SECURED LOAN NOTES TOTALLING A$300,000,000
MELBOURNE, Australia, May 2, 2024 /PRNewswire/ — Chevron Apartments Pty Ltd ACN 620 459 118 is seeking to raise a total of A$300,000,000 in funds by the issue of loan notes, according to an announcement today by the underwriter Banner Capital Management Limited (the Arranger/Underwriter).
TRICORBRAUN ACQUIRES TWO AUSTRALIAN PACKAGING DISTRIBUTORS – UNIQUEPAK AND ALPLAS PRODUCTS
Acquisitions Expand TricorBraun’s Australian Presence and Strengthen Its Position as a Leading Packaging Provider in ANZ ST. LOUIS, May 2, 2024 /PRNewswire/ — Global packaging leader TricorBraun has acquired Australian spirits packaging distributor UniquePak and Australian industrial pa
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, May 1, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-1261 AMERICAN LITHIUM CORP. (“LI.WT”)BULLETIN TYPE: Warrant Expiry-DelistBULLETIN DATE: May 1, 2024TSX Venture Tier 2 Company Effective at the opening, May 9, 2024, the Share Purchase Warrants of the Comp
EXAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Exscientia p.l.c. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, May 1, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Exscientia p.l.c. (“Exscientia” or “the Company”) (NASDAQ: E
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
– Leverages Poseida’s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors – TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) an
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, May 1, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Akero Therapeutics, Inc. (“Akero” or “the Company”) (NASDAQ:
Pangea Entertainment Productions and Big Bang Mediaverse announce co-production partnership
LOS ANGELES, May 1, 2024 /PRNewswire/ — Pangea Entertainment Productions (Venice, Ca.) and Big Bang Mediaverse (Mumbai, India) announce a partnership to create and produce innovative multiplatform content aimed at younger and connected audiences globally and in India. The first program in co-d
AXA partners with Prosper Health to expand “Healthcare and Wellness Ecosystem” in China
First global insurer in Hong Kong to collaborate with Prosper Health, providing seamless cross-border healthcare services HONG KONG, April 30, 2024 /PRNewswire/ — AXA Hong Kong and Macau (“AXA”) announced a partnership with Prosper Health, a health insurance service provider under
BTQ TECHNOLOGIES CORP. PROVIDES BI-WEEKLY MCTO STATUS UPDATE
VANCOUVER, BC, May 1, 2024 /PRNewswire/ – BTQ Technologies Corp. (the “Company”) (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF) is providing this bi-weekly update on the status of the management cease trade order issued on April 3, 2024 (the “MCTO”), by its principal regulat
